These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12744901)

  • 21. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 22. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of antibodies for measles among vaccinated medical students in Italy.
    Coppeta L; Somma G; Di Giampaolo L; Bizzarro G; Ippoliti L; Borelli F; Balbi O; Perrone S; Pietroiusti A
    Infect Dis (Lond); 2020 Aug; 52(8):593-595. PubMed ID: 32484374
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles vaccine: do we need new vaccines or new programs?
    Katz SL; Gellin BG
    Science; 1994 Sep; 265(5177):1391-2. PubMed ID: 8073281
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interruption of measles transmission in Gipuzkoa (Basque Country), Spain.
    Cilla G; Basterretxea M; Artieda J; Vicente D; Pérez-Trallero E
    Euro Surveill; 2004 May; 9(5):29-31. PubMed ID: 15208472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The resurgence of measles in the United States, 1989-1990.
    Atkinson WL; Orenstein WA; Krugman S
    Annu Rev Med; 1992; 43():451-63. PubMed ID: 1580601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles outbreak in a community with very low vaccine coverage, the Netherlands.
    van den Hof S; Meffre CM; Conyn-van Spaendonck MA; Woonink F; de Melker HE; van Binnendijk RS
    Emerg Infect Dis; 2001; 7(3 Suppl):593-7. PubMed ID: 11485681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population.
    Mossong J; O'Callaghan CJ; Ratnam S
    Vaccine; 2000 Oct; 19(4-5):523-9. PubMed ID: 11027817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Measles epidemiology in the Netherlands: a exploratory analysis of notification].
    Wallinga J; van den Hof S
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):171-4. PubMed ID: 10668543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.
    Atrasheuskaya AV; Kulak MV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2008 Apr; 26(17):2111-8. PubMed ID: 18343536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in 2017-2018.
    Plans-Rubió P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1719-1729. PubMed ID: 31289949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiology and evaluation of passive surveillance during 1988-1989 measles outbreak in Taiwan.
    Lee MS; King CC; Jean JY; Kao CL; Wang CC; Ho MS; Chen CJ; Lee GC
    Int J Epidemiol; 1992 Dec; 21(6):1165-74. PubMed ID: 1483823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles elimination: old and new challenges?
    Muller CP
    Vaccine; 2001 Mar; 19(17-19):2258-61. PubMed ID: 11257344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.